financetom
Business
financetom
/
Business
/
Eli Lilly's weight-loss drug succeeds in trials with sleep apnea patients
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly's weight-loss drug succeeds in trials with sleep apnea patients
Apr 17, 2024 3:49 AM

April 17 (Reuters) - Eli Lilly's ( LLY ) weight-loss

drug succeeded in two late-stage trials testing it in patients

with obstructive sleep apnea, the company said on Wednesday.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Sriraj

Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved